InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-26.4%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Cohen Fred E, Director. Officer active across 7 companies, notably CareDx, Inc.. In total, 28 disclosures have been published. Activity tracked since 16 June 2021. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations28 total
9,795 sharesCommon StockSEC:0001339358-26-000002:0
9,200 sharesCommon StockSEC:0001193125-26-266233:0
5,093 shares0Common StockSEC:0001193125-26-248434:0
10,570 shares0Common StockSEC:0000950170-24-074946:0
7,737 shares0Common StockSEC:0000950170-24-073689:0
6,176 shares0Common StockSEC:0001551306-24-000109:0
4,523,924 sharesCommon StockSEC:0000950170-24-015473:0
69,339 shares@ US$9.54100.0% of flowOrdinary SharesSEC:0001437749-23-021073:0
18,844 shares0Common StockSEC:0001217234-23-000123:0
4,425 shares0Common StockSEC:0001209191-23-037873:0
4,385 shares0Common StockSEC:0001628280-23-019974:0
1,062 shares0Common StockSEC:0001217234-23-000011:0
3,480 shares0Common StockSEC:0001628280-22-027102:0
803 shares0Common StockSEC:0001217234-22-000173:0
4,863 shares0Common StockSEC:0001217234-22-000125:0
5,197 shares0Common StockSEC:0001209191-22-037590:0
2,652 shares0Common StockSEC:0001179110-21-009630:0
2,652 shares0Common StockSEC:0001179110-21-009630
2,094 shares0Common StockSEC:0001209191-21-043362
2,094 shares0Common StockSEC:0001209191-21-043362:0
1,127 shares0Common StockSEC:0001217234-21-000140
1,127 shares0Common StockSEC:0001217234-21-000140:0
4,065 sharesCommon StockSEC:0001123292-16-001556:0
4,065 sharesCommon StockSEC:0001123292-16-001556:1
4,065 sharesCommon StockSEC:0001123292-16-001556:2
25 of 28 declarations
About Cohen Fred E
Fred E. Cohen is a Director at CareDx, Inc., Intellia Therapeutics, Inc., and Progyny, Inc. As a board member, he plays a key role in the governance of these companies and in shaping their strategy. His expertise in the healthcare sector and management experience contribute to performance evaluation and guiding policies.
